Henrick S Olsen

Title: Henrick S. Olsen: Innovator in Human Health Solutions

Introduction

Henrick S. Olsen is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have therapeutic applications. With a total of 2 patents, his work focuses on addressing critical health issues related to electrolyte imbalances and blood disorders.

Latest Patents

Olsen's latest patents include the development of a human stanniocalcin-alpha polypeptide. This invention encompasses a DNA (RNA) encoding such polypeptide and a procedure for producing it through recombinant techniques. The applications of this polypeptide are crucial for regulating electrolyte imbalances that can lead to renal, bone, and heart diseases, as well as conditions like osteoporosis and Paget's Disease. Additionally, his work includes antagonists against these polypeptides, which can help manage hypocalcemia and osteoporosis.

Another significant patent involves human haemopoietic maturation factor polypeptides. This invention also includes DNA (RNA) encoding these polypeptides and a method for their production via recombinant techniques. The therapeutic potential of these polypeptides lies in their ability to treat leukemia, autoimmune diseases, and blood-related disorders. Furthermore, the patent discloses diagnostic assays that can detect mutations in the haemopoietic maturation factor nucleic acid sequences and altered protein levels.

Career Highlights

Henrick S. Olsen is associated with Human Genome Sciences, Inc., where he has been instrumental in advancing research in human health. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to the development of therapies that address significant medical challenges.

Collaborations

Olsen has collaborated with notable colleagues, including Robert D. Fleischmann and Ewen F. Kirkness. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking health solutions.

Conclusion

Henrick S. Olsen's contributions to biotechnology through his patents and collaborations highlight his commitment to improving human health. His innovative approaches to addressing electrolyte imbalances and blood disorders demonstrate the potential for significant advancements in medical treatments.